The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study
NCT04956393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2023-12-26
Summary
Adolescents and young adults who hurt their knees playing sports or doing recreational activities can develop joint damage, muscle weakness, inactivity, and weight gain which might lead to an increased risk of osteoarthritis (OA), a disabling joint condition in their later lives. Despite knowing that muscles and joints benefit from exercise, there is no proven exercise-based treatments to delay or even halt the onset of OA after a knee joint injury.
The current study will assess if a physiotherapist-guided intervention called Stop OsteoARthritis (SOAR) improves knee muscle strength, physical inactivity, knee-related self-efficacy, and knee-related quality of life in people at risk for osteoarthritis due to a past knee injury. A total of 70 former knee injury participants will be randomly assigned to two groups. One group will immediately start a 16-week SOAR program, while the second will wait for 9-weeks before starting an 8-week SOAR program. Trained physiotherapists will deliver the SOAR program with videoconferencing. The study hypothesis is that participating in the 8-Week SOAR program will improve the knee muscle strength, physical activity levels, knee-related self-efficacy and knee-related quality of life in people discharged from regular healthcare after a sports knee injury. The findings will help researchers understand the ideal length of the program for a future clinical trial in real-world settings.
Conditions
- Arthritis
- Osteoarthritis
- Arthritis Knee
- Osteo Arthritis Knee
- Knee Injuries
- Anterior Cruciate Ligament Tear
- Meniscus Tear
Interventions
- BEHAVIORAL
-
Immediate 8-Week SOAR Program
This is an 8-week, virtually delivered, exercise-based, knee health program delivered to knee injury participants by trained physiotherapists. The program has 3 components: 1. Knee Camp: This includes an interactive education session about knee health, 1:1 knee exam, and 1:1 counseling session to identify Specific, Measurable, Attainable, Relevant, and Time-bound (SMART) weekly home-based exercise-therapy and physical activity goals, Participants are asked to wear Fitbit's® 24-hours/day. 2. Weekly Home-based Exercise-Therapy and Physical Activity, with Tracking: At home, participants work to meet their exercise-therapy and physical activity goals. Exercises are tracked with an online bespoke form and activity, with a Fitbit. 3. Weekly PT-guided Exercise-Therapy and Physical Activity Counseling Sessions: Each week participants will attend a 1:1 virtual physiotherapist counseling session to modify SMART goals and have the option to attend a group exercise class.
- BEHAVIORAL
-
Delayed 8-Week SOAR Program
This is an 8-week, virtually delivered, exercise-based, knee health program delivered to knee injury participants by trained physiotherapists. The program has 3 components: 1. Knee Camp: This includes an interactive education session about knee health, 1:1 knee exam, and 1:1 counseling session to identify Specific, Measurable, Attainable, Relevant, and Time-bound (SMART) weekly home-based exercise-therapy and physical activity goals, Participants are asked to wear Fitbit's® 24-hours/day. 2. Weekly Home-based Exercise-Therapy and Physical Activity, with Tracking: At home, participants work to meet their exercise-therapy and physical activity goals. Exercises are tracked with an online bespoke form and activity, with a Fitbit. 3. Weekly PT-guided Exercise-Therapy and Physical Activity Counseling Sessions: Each week participants will attend a 1:1 virtual physiotherapist counseling session to modify SMART goals and have the option to attend a group exercise class.
Sponsors & Collaborators
-
The Arthritis Society, Canada
collaborator OTHER -
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
Michael Smith Foundation for Health Research
collaborator OTHER -
University of British Columbia
lead OTHER
Principal Investigators
-
Jackie L Whittaker, PhD, PT · University of British Columbia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2023-02-28
- Completion
- 2023-04-15
Countries
- Canada
Study Locations
More Related Trials
-
Evaluation of the Effect of Pro Resolve® Sports on Treatment of Patients With Symptomatic Knee Osteoarthritis
NCT05633849 ·Status: COMPLETED ·Phase: NA
-
Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement
NCT00911469 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
NCT00988091 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)
NCT02095548 ·Status: COMPLETED ·Phase: PHASE1
-
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
NCT03491761 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
NCT00604539 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Osteoarthritis With Autologous, Microfragmented Adipose Tissue.
NCT03771989 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
NCT02536833 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis
NCT07329361 ·Status: RECRUITING ·Phase: NA
-
A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain
NCT00394563 ·Status: COMPLETED ·Phase: PHASE2
-
Intraarticular Platelet-rich Plasma Injections Versus Corticosteroid Injections in Primary Knee Osteoarthritis
NCT01923909 ·Status: WITHDRAWN ·Phase: PHASE4
-
Knee Injections for Obese Patients With Knee Arthritis
NCT06782529 ·Status: RECRUITING ·Phase: PHASE4
-
Adalimumab for Inflammatory Osteoarthritis
NCT00686439 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacist-initiated Intervention Trial in OsteoArthritis (PhIT-OA)
NCT00391859 ·Status: COMPLETED ·Phase: NA
-
An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA
NCT03661996 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
NCT01111045 ·Status: COMPLETED ·Phase: PHASE2
-
Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
NCT00450112 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of CG100649 in Osteoarthritis Patients
NCT01765296 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
NCT00837291 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effect of Weight Loss and Exercise on Knee Osteoarthritis
NCT00061490 ·Status: COMPLETED ·Phase: NA
-
The Impact of Procedural Awareness of Knee Injections for Osteoarthritis on Patient Perceptions of Effectiveness
NCT04111718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Immune-Mediated Pathophysiology And Clinical Triage Program
NCT04354649 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement
NCT00454298 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I
NCT01463488 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Different Injection Regimens of Autologous Conditioned Plasma for Knee Osteoarthritis
NCT03889925 ·Status: COMPLETED ·Phase: PHASE2/PHASE3